Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2005-11-25 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CARCASSONNE (11000), Aude
GRANDE PHARMACIE DE LA GARE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE LA GARE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CARCASSONNE (11000),
this company of category PME
shows in 2022 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE LA GARE (SIREN 485172357)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
N/C
N/C
3 133 804 €
N/C
N/C
N/C
8 022 035 €
9 697 176 €
10 686 664 €
11 300 976 €
11 432 289 €
Net income
235 732 €
-482 106 €
-499 073 €
61 864 €
83 287 €
285 486 €
32 925 €
62 727 €
165 698 €
277 821 €
338 657 €
EBITDA
N/C
N/C
-449 197 €
N/C
N/C
N/C
-53 691 €
123 951 €
189 200 €
409 556 €
529 898 €
Net margin
N/C
N/C
-15.9%
N/C
N/C
N/C
0.4%
0.6%
1.6%
2.5%
3.0%
Revenue and income statement
In 2024, GRANDE PHARMACIE DE LA GARE generates positive net income of 236 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 339 k€ -> 236 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
235 732 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2099%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2098.768%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
3.357%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
105.503
75.753
51.791
71.427
117.997
93.151
171.71
156.878
199.026
-3048.037
2098.768
Financial autonomy
27.381
33.606
37.372
34.529
31.194
34.685
27.87
29.931
24.699
-2.551
3.357
Repayment capacity
2.805
2.999
3.796
6.592
-12.097
None
None
None
-4.419
None
None
Cash flow / Revenue
3.989%
3.33%
2.114%
1.325%
-1.397%
None%
None%
None%
-15.555%
None%
None%
Sector positioning
Debt ratio
2098.772024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of GRANDE PHARMACIE DE LA GARE (2098.77) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
3.36%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of GRANDE PHARMACIE DE LA GARE (3.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
-4.42 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of GRANDE PHARMACIE DE LA GARE (-4.42) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 261.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
261.667
Liquidity indicators evolution GRANDE PHARMACIE DE LA GARE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
147.373
164.18
158.43
150.322
193.27
204.127
306.17
326.523
300.299
313.251
261.667
Interest coverage
7.494
7.391
13.527
17.547
-29.694
None
None
None
-2.064
None
None
Sector positioning
Liquidity ratio
261.672024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of GRANDE PHARMACIE DE LA GARE (261.67) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-2.06x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of GRANDE PHARMACIE DE LA GARE (-2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
2 145 269 €
2 477 739 €
2 625 606 €
2 451 543 €
1 946 787 €
0 €
0 €
0 €
1 801 593 €
0 €
0 €
Inventory turnover (days)
55
54
61
62
59
0
0
0
188
0
0
Customer payment term (days)
10
14
12
15
14
0
0
0
17
0
0
Supplier payment term (days)
60
58
64
63
49
0
0
0
98
0
0
Positioning of GRANDE PHARMACIE DE LA GARE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE LA GARE is estimated at
3 290 992 €
(range 2 291 795€ - 4 923 513€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2291k€3290k€4923k€
3 290 992 €Range: 2 291 795€ - 4 923 513€
NAF 5 année 2024
Valuation method used
Net Income Multiple
235 732 €
×
14.0x
=3 290 993 €
Range: 2 291 795€ - 4 923 514€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE LA GARE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE LA GARE
What is the revenue of GRANDE PHARMACIE DE LA GARE ?
The revenue of GRANDE PHARMACIE DE LA GARE in 2022 is 3.1 M€.
Is GRANDE PHARMACIE DE LA GARE profitable?
Yes, GRANDE PHARMACIE DE LA GARE generated a net profit of 236 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE LA GARE ?
The headquarters of GRANDE PHARMACIE DE LA GARE is located in CARCASSONNE (11000), in the department Aude.
Where to find the tax return of GRANDE PHARMACIE DE LA GARE ?
The tax return of GRANDE PHARMACIE DE LA GARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE LA GARE operate?
GRANDE PHARMACIE DE LA GARE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart